Showing results (1-10 of 19) with videos related to
Sort By:
Pageof 2
Oncoimmunology|September 14, 2016
Combined treatment with dabrafenib and trametinib with immune-stimulating antibodies for BRAF mutant melanomaBlanca Homet Moreno, Stephen Mok, Begonya Comin-Anduix, et al.Proceedings of the National Academy of Sciences of the United States of America|June 26, 2024
Post-immunotherapy CTLA-4 Ig treatment improves antitumor efficacyStephen Mok, Didem Ağaç Çobanoğlu, Huey Liu, et al.Cancer Research|February 19, 2013
CSF1R signaling blockade stanches tumor-infiltrating myeloid cells and improves the efficacy of radiotherapy in prostate cancerJingying Xu, Jemima Escamilla, Stephen Mok, et al.BMC Cancer|May 6, 2015
Inhibition of colony stimulating factor-1 receptor improves antitumor efficacy of BRAF inhibitionStephen Mok, Jennifer Tsoi, Richard C Koya, et al.Proceedings of the National Academy of Sciences of the United States of America|January 9, 2025
Anti-CTLA-4 generates greater memory response than anti-PD-1 via TCF-1Stephen Mok, Huey Liu, Didem Ağaç Çobanoğlu, et al.Proceedings of the National Academy of Sciences of the United States of America|July 14, 2010
Kinetic phases of distribution and tumor targeting by T cell receptor engineered lymphocytes inducing robust antitumor responsesRichard C Koya, Stephen Mok, Begoña Comin-Anduix, et al.Cancer Research|November 20, 2013
Inhibition of CSF-1 receptor improves the antitumor efficacy of adoptive cell transfer immunotherapyStephen Mok, Richard C Koya, Christopher Tsui, et al.Cancer Research|November 18, 2015
An Effective Immuno-PET Imaging Method to Monitor CD8-Dependent Responses to ImmunotherapyRichard Tavaré, Helena Escuin-Ordinas, Stephen Mok, et al.Oncoimmunology|August 2, 2014
Distinct immunological mechanisms of CTLA-4 and PD-1 blockade revealed by analyzing TCR usage in blood lymphocytesLidia Robert, Christina Harview, Ryan Emerson, et al.Cancer Research|June 14, 2012
BRAF inhibitor vemurafenib improves the antitumor activity of adoptive cell immunotherapyRichard C Koya, Stephen Mok, Nicholas Otte, et al.Pageof 2